Management of hypogonadism: is there a role for salivary testosterone

Endocrine

Volumn 50, Issue 1, 2015, Pages

  Fiers, Tom ^a   Kaufman, Jean Marc ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

AGING; ANDROGEN DEFICIENCY; CLINICAL FEATURE; EDITORIAL; EQUILIBRIUM DIALYSIS; GOLD STANDARD; HUMAN; HYPOGONADISM; IMMUNOASSAY; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; PRIORITY JOURNAL; SALIVA LEVEL; SYMPTOM; TANDEM MASS SPECTROMETRY; TESTOSTERONE BLOOD LEVEL; ULTRAFILTRATION; MALE; METABOLISM;

AGING; HUMANS; HYPOGONADISM; MALE; TESTOSTERONE;

EID: 84940435126     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-015-0650-6     Document Type: Editorial

References (12)

1. L.D. Hayes et al., Salivary testosterone measurement does not identify biochemical hypogonadism in aging men: a ROC analysis. Endocrine (2014). doi:10.1007/s12020-014-0516-3
2. S. Bhasin, G.R. Cunningham, F.J. Hayes, A.M. Matsumoto, P.J. Snyder, R.S. Swerdloff, V.M. Montori, Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 91, 1995–2010 (2006)
3. J.C. Botelho, C. Shacklady, H.C. Cooper, S.S. Tai, K. Van Uytfanghe, L.M. Thienpont, H.W. Vesper, Isotope-dilution liquid chromatography-tandem mass spectrometry candidate reference method for total testosterone in human serum. Clin. Chem. 59, 372–380 (2013)
4. J. Taieb, B. Mathian, F. Millot, M.C. Patricot, E. Mathieu, N. Queyrel, I. Lacroix, C. Somma-Delpero, P. Boudou, Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. Clin. Chem. 49, 1381–1395 (2003)
5. I.T. Huhtaniemi et al., Comparison of serum testosterone and estradiol measurements in 3174 European men using platform immunoassay and mass spectrometry; relevance for the diagnostics in aging men. Eur. J. Endocrinol. 166, 983–991 (2012)
6. A. Vermeulen, L. Verdonck, J.M. Kaufman, a critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol. Metab. 84, 3666–3672 (1999)
7. M.N. Zakharov, S. Bhasin, T.G. Travison, R. Xue, J. Ulloor, R.S. Vasan, E. Carter, F. Wu, R. Jasuja, A multi-step, dynamic allosteric model of testosterone’s binding to sex hormone binding globulin. Mol. Cell. Endocrinol. 399, 190–200 (2015)
8. H. Raff, Utility of salivary cortisol measurements in Cushing’s syndrome and adrenal insufficiency. J. Clin. Endocrinol. Metab. 94, 3647–3655 (2009). doi:10.1210/jc.2009-1166
9. R. Miller, F. Plessow, M. Rauh, M. Gröschl, C. Kirschbaum, Comparison of salivary cortisol as measured by different immunoassays and tandem mass spectrometry. Psychoneuroendocrinology 38, 50–57 (2013)
10. D. Granger, E. Shirtcliff, A. Booth, K. Kivlighan, E. Schwartz, The ‘‘trouble’’ with salivary testosterone. Psychoneuroendocrinology 29, 1229–1240 (2004)
11. T. Fiers, J. Delanghe, G. T’Sjoen, E. Van Caenegem, K. Wierckx, J.M. Kaufman, A critical evaluation of salivary testosterone as a method for the assessment of serum testosterone. Steroids 86, 5–9 (2014)
12. J.S. Mitchell, T.E. Lowe, Matrix effects on an antigen immobilized format for competitive enzyme immunoassay of salivary testosterone. J. Immunol. Methods 349, 61–66 (2009)